Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process
Authors:
Open Access
- 1 November 2011
- journal article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. 6, 2997-3009
Abstract
Peer reviewed article authored by (Kim MS, Kim JS, Park HJ, Cho WK, Cha KH, Hwang SJ). Read article or submit your manuscript for publishing.Keywords
This publication has 34 references indexed in Scilit:
- Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerationsExpert Opinion on Drug Delivery, 2011
- New Insights into Drug AbsorptionTherapeutic Drug Monitoring, 2004
- Liposomal Formulations of Tacrolimus and Rapamycin Increase Graft Survival and Fiber Outgrowth of Dopaminergic GraftsCell Transplantation, 2004
- CYP3A4-Transfected Caco-2 Cells as a Tool for Understanding Biochemical Absorption Barriers: Studies with Sirolimus and MidazolamThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Evaluation of solid dispersion particles prepared with SEDSInternational Journal of Pharmaceutics, 2003
- Identification of a Novel Route of Extraction of Sirolimus in Human Small Intestine: Roles of Metabolism and SecretionThe Journal of Pharmacology and Experimental Therapeutics, 2002
- The mechanisms of drug release from solid dispersions in water-soluble polymersInternational Journal of Pharmaceutics, 2002
- Sirolimus Oral Absorption in Rats Is Increased by Ketoconazole but Is Not Affected by d-α-Tocopheryl Poly(Ethylene Glycol 1000) SuccinateThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Solubilization of rapamycinInternational Journal of Pharmaceutics, 2001
- Therapeutic monitoring of sirolimus in human whole-blood samples by high-performance liquid chromatographyClinical Therapeutics, 2000